This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Value of Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Tobias J. Weismueller, Hannover Medical School
ClinicalTrials.gov Identifier:
NCT00942630
First received: July 20, 2009
Last updated: October 7, 2011
Last verified: October 2011
  Purpose
In a prospective study the investigators perform repeated cholangioscopies in all patients that received percutaneous transhepatic biliary drainage (PTBD) for a variety of malignant and benign diseases. Endoscopic findings and their correlation with clinical features will be recorded prospectively. The impact on clinical decision will be evaluated.

Condition
Bile Duct Stricture Not Treatable by ERC

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Percutaneous Cholangioscopy After Placement of a Percutaneous Transhepatic Biliary Drainage (PTBD) - a Prospective Study on Endoscopic Findings and Clinical Impact

Further study details as provided by Tobias J. Weismueller, Hannover Medical School:

Estimated Enrollment: 40
Study Start Date: March 2008
Study Completion Date: April 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   1 Year and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All patients receiving a PTBD
Criteria

Inclusion Criteria:

PTBD with at least 14 French in diameter

Exclusion Criteria:

missing informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00942630

Locations
Germany
Hannover Medical School
Hannover, Germany
Sponsors and Collaborators
Hannover Medical School
  More Information

Responsible Party: Tobias J. Weismueller, Dr. T. Weismüller, Hannover Medical School
ClinicalTrials.gov Identifier: NCT00942630     History of Changes
Other Study ID Numbers: MHH-ENDO-0709
Study First Received: July 20, 2009
Last Updated: October 7, 2011

Keywords provided by Tobias J. Weismueller, Hannover Medical School:
percutaneous
transhepatic
biliary
drainage
cholangioscopy

ClinicalTrials.gov processed this record on September 21, 2017